Paloma Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,635
Closed -$484K 550
2024
Q3
$484K Buy
+18,635
New +$463K 0.01% 632
2024
Q2
Sell
-13,712
Closed -$325K 1306
2024
Q1
$325K Buy
+13,712
New +$305K 0.02% 501
2021
Q3
Sell
-64,581
Closed -$1.18M 1335
2021
Q2
$1.18M Buy
+64,581
New +$1.51M 0.02% 569
2020
Q3
Sell
-114,251
Closed -$2.71M 2193
2020
Q2
$2.71M Buy
+114,251
New +$2.65M 0.05% 507
2019
Q4
Sell
-25,024
Closed -$442K 2258
2019
Q3
$442K Sell
25,024
-33,520
-57% -$678K 0.01% 1252
2019
Q2
$1.25M Sell
58,544
-72,372
-55% -$1.52M 0.02% 604
2019
Q1
$3.12M Buy
130,916
+80,972
+162% +$1.85M 0.08% 303
2018
Q4
$982K Buy
49,944
+29,244
+141% +$521K 0.03% 461
2018
Q3
$367K Buy
+20,700
New +$404K 0.01% 1148
2018
Q2
Sell
-24,667
Closed -$546K 1789
2018
Q1
$546K Buy
24,667
+13,780
+127% +$381K 0.01% 1312
2017
Q4
$330K Buy
+10,887
New +$290K ﹤0.01% 1501
2017
Q3
Sell
-296,330
Closed -$7.3M 2175
2017
Q2
$7.3M Buy
296,330
+257,279
+659% +$5.44M 0.09% 211
2017
Q1
$847K Buy
+39,051
New +$794K 0.01% 1326
2016
Q1
Sell
-67,052
Closed -$378K 1902
2015
Q4
$378K Buy
+67,052
New +$375K 0.01% 1204
2013
Q3
Sell
-12,106
Closed -$55K 999
2013
Q2
$55K Buy
+12,106
New +$57.4K ﹤0.01% 1102

Other funds holding EXEL

Paloma Partners's EXEL Position: Q4 2024 in Review

Paloma Partners sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 18,635 shares — an estimated $484K sold.

Paloma Partners first reported a position in EXEL in Q2 2013 and held it in 15 quarters. The position peaked at $7.3M in Q2 2017. 518 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.

  • Paloma Partners reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 18,635 Exelixis shares in Q4 2024, an estimated $484K.
  • Paloma Partners first reported a position in Exelixis in Q2 2013 and held it in 15 quarters.
  • Paloma Partners's Exelixis position peaked at $7.3M in Q2 2017.
  • 518 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.